Promethium Advisors
NVO icon

Promethium Advisors’s Novo Nordisk NVO Stock Holding History

Promethium Advisors’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.21M Buy
31,830
+5,175
+19% +$239K 0.59% 46
2026
Q2 		$1.28M Buy
26,655
+20,730
+350% +$891K 0.61% 47
2026
Q1 		$223K Buy
+5,925
New +$281K 0.12% 105

Other funds holding NVO

Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Everett Harris & Co
Everett Harris & Co Los Angeles, California $8.46B AUM 13.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Saratoga Research & Investment Management
Saratoga Research & Investment Management Saratoga, California $1.82B AUM 11.8% 1-Year Est. Return
Markel Group
Markel Group Glen Allen, Virginia $12.8B AUM 8.77% 1-Year Est. Return
Natixis
Natixis Paris, France $28B AUM 27.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $313B AUM 26.62% 1-Year Est. Return

Promethium Advisors's NVO Position: Q3 2026 in Review

Promethium Advisors increased its Novo Nordisk (NVO) stake by 19% in Q3 2026, buying an estimated $239K and bringing the position to 31,830 shares worth $1.21M. The position accounts for 0.59% of the portfolio, ranked #46.

Promethium Advisors first reported a position in NVO in Q1 2026 and has held it in 3 quarters since. The position peaked at $1.28M in Q2 2026. 816 funds tracked by Wall St. Rank hold NVO as of Q3 2026.

  • Promethium Advisors held 31,830 shares of Novo Nordisk worth $1.21M as of Q3 2026.
  • Promethium Advisors bought 5,175 Novo Nordisk shares in Q3 2026, an estimated $239K.
  • Novo Nordisk made up 0.59% of Promethium Advisors's portfolio in Q3 2026, its #46 holding.
  • Promethium Advisors first reported a position in Novo Nordisk in Q1 2026 and has held it in 3 quarters since.
  • Promethium Advisors's Novo Nordisk position peaked at $1.28M in Q2 2026.
  • 816 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.

Based on Promethium Advisors's 13F filing for Q3 2026, filed 19 Oct 2026.